Where does Transdermal Biotechnology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Transdermal Biotechnology, Inc. ranks #3,988 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Transdermal Biotechnology, Inc. hold?

Transdermal Biotechnology, Inc. holds 91 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Transdermal Biotechnology, Inc.'s Innovation Score?

Transdermal Biotechnology, Inc. has an Innovation Score of 41.5 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Transdermal Biotechnology, Inc.'s patent grant rate increasing or decreasing?

Transdermal Biotechnology, Inc.'s recent grant velocity is -95% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Transdermal Biotechnology, Inc.'s patents?

Transdermal Biotechnology, Inc.'s patents average 20.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Transdermal Biotechnology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Transdermal Biotechnology, Inc.

Q: What technology areas does Transdermal Biotechnology, Inc. focus on?

Transdermal Biotechnology, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 91 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 91 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Transdermal ranks #3,988 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 8 technology areas.

#3,988
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.5/100): 20.9
avg claims per patent: -95%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3988 · US Corporation #3,988 · 91 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 91 grants
TOP-DECILE #3,988/49,997
PHOTO-FINISH Saint Louis University
CPC-NARROW A61K · 8 areas
INNOV-PAR 41.5/100
CLAIMS-DENSE 20.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -95% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Saint Louis University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
E-lead · near

41
Guangzhou Shiyuan · near

41
Transdermal… · this assignee

41
VeroScience · near

41
Irwin Industrial Tool · near

41
3D Lighting… · lowest

7

What this shows Transdermal's Innovation Score is 41.5/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Transdermal's grants concentrate

Transdermal Biotechnology, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (26 grants) versus a trough of 1 in 2020. By volume, Transdermal sits between Saint Louis University and Whirlpool S.A..

Transdermal's three-year grant acceleration

Transdermal Biotechnology, Inc. shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Saint Louis Unive…

91
Silgan White Cap

91
Tango Networks

91
Tsmc Nanjing

91
Transitions Optic…

91
Treace Medical Co…

91
University of Man…

91
Whirlpool

91
Transdermal Biote… ◀

91

What this shows Transdermal holds 91 patents at rank #3,989, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Transdermal

By rank, the assignees closest to #3,989 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Transdermal's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Transdermal, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

E-lead Electronic Co., Ltd. 41 Guangzhou Shiyuan Electronics Co., Ltd. 41 VeroScience LLC 41 Irwin Industrial Tool Company 41

Similar claim depth

Nearest assignees by average claims per patent (20.9 here).

STMicroelectronics Application GMBH 20.9 avg Verisign, Inc. 20.9 avg Memorial Sloan Kettering Cancer Center 20.9 avg Woodwelding AG 20.9 avg

Transdermal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Transdermal Biotechnology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	11.0%
2016	26	28.6%
2017	23	25.3%
2018	22	24.2%
2019	5	5.5%
2020	1	1.1%
2022	1	1.1%
2024	2	2.2%
2025partial year	1	1.1%

Which technologies does Transdermal Biotechnology, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 91

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 46

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 16

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 13

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

C12Y - Enzymes 2

C07K - Peptides 2

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#3,988

of 49,997 tracked assignees

Innovation Score

41.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Transdermal Biotechnology, Inc.'s patent record in context - here's where to go next.

Transdermal Biotechnology, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,988 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Transdermal Biotechnology, Inc. against Saint Louis University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.